European CE Mark Approval
-
Extremities
NuVasive’s Proprietary Magnetic Implant System To Be Used In First-Of-Its-Kind, All-Internal Bone Transport System
SAN DIEGO, Feb. 19, 2019 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with…
Read More » -
Biologics
Regentis Biomaterials Receives European CE Mark Approval for GelrinC
OR AKIVA, Israel and PRINCETON, New Jersey, August 28, 2017 /PRNewswire/ — Regentis Biomaterials Ltd., a privately held company developing proprietary hydrogels for tissue regeneration,…
Read More »